Context Therapeutics Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$0.07 | -$0.07 | -$0.07 |
| Q2 2024 | 1 | -$0.09 | -$0.09 | -$0.09 |
| Q3 2024 | 2 | -$0.07 | -$0.05 | -$0.06 |
| Q1 2025 | 1 | -$0.06 | -$0.06 | -$0.06 |
| Q2 2025 | 1 | -$0.06 | -$0.06 | -$0.06 |
| Q3 2025 | 1 | -$0.07 | -$0.07 | -$0.07 |
| Q4 2025 | 1 | -$0.07 | -$0.07 | -$0.07 |
Context Therapeutics Inc. Earnings Date And Information
Context Therapeutics Inc. last posted its earnings results on Wednesday, November 6th, 2024. The company reported $-0.22 earnings per share for the quarter, missing analysts' consensus estimates of $-0.1 by $0.12. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Context Therapeutics Inc. has generated $-2 earnings per share over the last year ($-1.5 diluted earnings per share) and currently has a price-to-earnings ratio of -3.71. Context Therapeutics Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 19th, 2025 based on prior year's report dates.
Context Therapeutics Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/06/2024 | Q3 2024 | -$0.10 | -$0.22 | -0.12 | $0 | $0 |
| 08/07/2024 | Q2 2024 | -$0.08 | -$0.04 | 0.04 | $0 | $0 |
| 05/08/2024 | Q1 2024 | -$0.38 | -$0.23 | 0.15 | $0 | |
| 03/21/2024 | Q4 2023 | -$0.35 | -$0.42 | -0.07 | $18,952 | |
| 11/09/2023 | Q3 2023 | -$0.30 | -$0.37 | -0.07 | $0 | |
| 08/09/2023 | Q2 2023 | -$0.20 | -$0.31 | -0.11 | $0 | |
| 05/10/2023 | Q1 2023 | -$0.19 | -$0.37 | -0.18 | $0 | |
| 03/22/2023 | Q4 2022 | -$0.30 | -$0.20 | 0.1 | $0 | |
| 11/09/2022 | Q3 2022 | -$0.25 | -$0.23 | 0.02 | $0 | |
| 08/11/2022 | Q2 2022 | -$0.25 | -$0.25 | 0 | $0 | |
| 05/11/2022 | Q1 2022 | -$0.24 | -$0.21 | 0.03 | $0 | |
| 03/23/2022 | Q4 2021 | -$0.30 | $0 | |||
| 12/02/2021 | Q3 2021 | -$0.14 | $0 | |||
| 06/29/2021 | Q2 2021 | -$0.73 | $0 | |||
| 03/30/2021 | Q1 2021 | -$0.09 | $0 | |||
| 12/30/2020 | Q4 2020 | -$0.08 | $0 | |||
| 09/29/2020 | Q3 2020 | -$0.09 | $0 | |||
| 06/29/2020 | Q2 2020 | $1.71 | $0 | |||
| 03/30/2020 | Q1 2020 | $0.19 | $0 |
Context Therapeutics Inc. Earnings: Frequently Asked Questions
-
When is Context Therapeutics Inc.'s earnings date?
Context Therapeutics Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 19th, 2025 based off last year's report dates.
-
How can I listen to Context Therapeutics Inc.'s earnings conference call?
The conference call for Context Therapeutics Inc.'s latest earnings report can be listened to online.
-
How can I read Context Therapeutics Inc.'s conference call transcript?
The conference call transcript for Context Therapeutics Inc.'s latest earnings report can be read online.
-
How much profit does Context Therapeutics Inc. generate each year?
Context Therapeutics Inc. (:CNTX) has a recorded net income of $0. Context Therapeutics Inc. has generated $-1.5 earnings per share over the last four quarters.
-
What is Context Therapeutics Inc.'s price-to-earnings ratio?
Context Therapeutics Inc. (:CNTX) has a price-to-earnings ratio of -3.71 and price/earnings-to-growth ratio is -0.26.
